In the TME of progressive BCP-ALL, anti-tumor immune cells, such as natural killer (NK) cells and CD8+ T cells, are prone to exhaust, lose or attenuate their cytotoxic activity against tumor cells, thus promoting tumor cell survival and proliferation (6, 7). Here, CD8A is linked to neoplasm.